Trial Profile
A Placebo-Controlled, Randomised, Double-Blind Trial to Assess the Safety and Efficacy of Intermittent Bilateral Intraputamenal (GDNF) Infusions Administered Via Convection Enhanced Delivery (CED) in Subjects With Parkinson&Apos;s Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Liatermin (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 22 Dec 2020 Data from this and other study (NCT04257656) was used to demonstrate the use of two plots identified to be beneficial for wide use in RCTs, Results published in the Trials
- 23 Aug 2018 Status changed from recruiting to completed.
- 16 Jul 2012 New trial record